1Liggins GC, Howie RN. A controlled trial of antepartum glucocorticoid treatment for prevention of the respiratory distress syndrome in premature infants. Pediatrics, 1972, 50 (4): 515-525.
2Ballard PL, Ballard RA. Scientific basis and therapeutic regimens for use of antenatal glucocorticoids. Am J Obstet Gynecol, 1995, 173 (1):254-262.
4National institutes of health consensus development conference statement, on the effect of corticosteroids for fetal maturation on perinatal outcomes. Am J Obstet Gynecol, 1995, 173 (1): 246-252.
5Egerman RS, Mercer BM, Doss JL, et al. A randomized trial of oral and intramuscular dexamethasone in the prevention of neonatal respiratory distress syndrome. Am J Obstet Gynecol, 1998, 179 (5): 1120-1123.
6Ljubic A, Cvetkovic M, Sulovic V, et al. New technique for artificial lung maturation. direct intramuscular fetal corticosteroid therapy. Clin Exp Obstet Gynecol, 1999, 26 (1): 16-19.
7Crowley P. Prophylactic corticosteroids for preterm birth. Cochrane Database Syst Rew, 2000, (2): CD000065.
9Jobe AH, Wada N, Berry LM, et al. Single and repetitive maternal glucocorticoid exposures reduce fetal growth in sheep. Am J Obstet Gynecol,1998, 78 (5): 880-885.
10French NP, Hagan R, Evans SF, et al. Repeated antenatal corticosteroid: size at birth and subsequent development. Am J Obstet Gynecol, 1999, 180 (1): 114-121.
二级参考文献14
1[1]Gonzales LW, Bailard P. Hormones and receptora[C].In:Massaro BLung Cell Biology[M]. New York: Marcel Dekker, 1989.539～589.
2[2]Gross I. Regulation of fetal lung maturation[J].Am J Physiol,1990, 259:1337 ～ L344.
3[3]Gross I, Wilson CM. Fetsl rat lung maturation: initiation and modulation[J].J Appl Physiol Respir Environ Exercise Physiol, 1983,55:1725 ～ 1732.
4[4]Evans RM. The steroid and thyroid hormone receptor superfamily [J]. Science, 1988, 240: 889 ～ 895.
5[5]Gross I, Ballnrd PL, Ballard RA, et al. Corticosteroid stimulation of phosphalidylcholine synthesis in cultured fetal rabbit lung. Evidence for de novo protein synthesis mediated by gIucocorticoid receptora[ J ]. Endocrimology, 1983, 112: 829～837.
6[6]Gucttari N, Dufour ME, Matin L. Effects of the antiglucocorlicoid RU 486 on the initiation of ultrastructural type- Ⅱ cell differen tiation in fetal rat lun g[J ]. Biol Neonate, 1990, 58:173 ～ 180.
7[7]Guettarl N, Matin L, Bourbon J, et al. Effects of the antiglucocorticoid RU486 on the maturation of fetal rat lung[J]. Exp Lung Res, 1989,15:151 ～ 166.
8[8]Miesfeld R, Okret S, Wikstrom AC, et al. Characterization of a steroid hormone receptor gene and mRNA in wild - type and mutant cells[J]. Nature, 1984, 312:779～781.
9[9]Miesfeld R. Molecular genetics of corticosteroid action[J]. Am Rev Respir Dis, 1990, 141:S11～S17.
10[10]Kalinyak JE, Dorin RI, Hoffman AR, et al. Tissue - specific regulation of glucocorticoid receptor Mrna by dexaincthasone[J].J Biol Chem, 1987, 262: 10441～ 10444.
7Alan HD,martin LP,current obstetric and Gynecologic dignosis and treat-ment, eight edition and Lange, 1994,333.
8Michael P. Fetal fibronectin in patients at increased risk for premature birth Am J Obstet Gynecol,1994,170:20.
9Merkat IR,peter JB, Barden TP. ritodrine hydrochloride: A betaminetic agent for use in preterm labor.Ⅱ evidence of efficacy,Obstet Gynecol, 1980,56: 7-12.
10James F. king, Adrian Grant, Marcj. N. C, keirse etc. Betaminetics in preterm labour:an Overview of the randomized controlled trials. Br Jobstet Gynecol, 1998,95 : 211 - 222.
